Company: WLTH
Filing Date: 2025-12-11
Form Type: S-1/A
Source: 0001628280-25-056439
Chunk: 403

Company: WEALTHFRONT CORP
Filing Date: 2025-12-11
Form: S-1/A
Chunk 403
---
 options                                                                   |     |                               |  28,567,993 |            |     |   |  27,962,907 |            |
| Dilutive effect of equity-classified common stock warrants                                         |     |                               |   1,210,425 |            |     |   |   1,300,400 |            |
| Weighted-average number of common stock outstanding used in computing earnings per share, dilutive |     |                               | 143,878,296 |            |     |   | 138,660,318 |            |
| Earnings per share attributable to common stockholders, diluted                                    |     | $                             |        0.54 |            |     | $ |        1.31 |            |

The following common stock equivalents were excluded from the computation of diluted earnings per share attributable to common stockholders because including them would have been antidilutive (outstanding):

|                                           |     | Fiscal Year Ended January 31, |       2024 |         |     |     |       2025 |         |
|:------------------------------------------|:----|:------------------------------|-----------:|:--------|:----|:----|-----------:|:--------|
| Liability-classified common stock warrant |     |                               |     60,000 |         |     |     |     60,000 |         |
| Series G Warrant                          |     |                               |    251,750 |         |     |     |    251,750 |         |
| Dual-trigger RSUs                         |     |                               | 22,177,257 |         |     |     | 31,308,443 |         |
| SAFEs                                     |     |                               |            | Various |     |     |            | Various |

#### 16.

### Financial Instruments with Off-Balance Sheet Credit Risk
As a securities broker, the Company executes transactions with and on behalf of clients. The Company clears these transactions with its clearing firm on an omnibus basis.

In the normal course of business, the Company’s client activities involve the execution of securities transactions and settlement by its clearing broker. The agreement between the Company and its clearing broker provides that the Company is obligated to assume any exposure related to nonperformance by its

<div align='center'>F-33</div>

### WEALTHFRONT CORPORATION
<div align='center'>Notes to Consolidated Financial Statements</div>

clients. These activities may expose the Company to off-balance sheet risk in the event